Related resources
Search for item elsewhere
University researcher(s)
Academic department(s)
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.
Relton J, Rothwell NJ
Brain Res Bull. 1992;29( 2):243-6.
Access to files
Full-text and supplementary files are not available from Manchester eScholar. Use our list of Related resources to find this item elsewhere. Alternatively, request a copy from the Library's Document supply service.
Abstract
Interleukin-1 (IL-1) synthesis in the brain is stimulated by mechanical injury and IL-1 mimics some effects of injury, such as gliosis and neovascularization. We report that neuronal death resulting from focal cerebral ischaemia (middle cerebral artery occlusion, 24 h) is significantly inhibited (by 50%) in rats injected with a recombinant IL-1 receptor antagonist (IL-1ra, 10 micrograms, icv 30 min before and 10 min after ischaemia). Excitotoxic damage due to striatal infusion of an NMDA-receptor agonist (cis-2,4-methanoglutamate) was also markedly inhibited (71%) by injection of the IL-1ra. These data indicate that endogenous IL-1 is a mediator of ischaemic and excitotoxic brain damage, and that inhibitors of IL-1 action may be of therapeutic value in the treatment of acute or chronic neuronal death.
Keyword(s)
Animals; Male; Rats; Rats, Inbred Strains; Receptors, Interleukin-1; Stereotaxic Techniques; Support, Non-U.S. Gov't; antagonists & inhibitors: Receptors, Immunologic; drug effects: Cell Death; drug effects: Neurons; drug effects: Receptors, N-Methyl-D-Aspartate; metabolism: Interleukin-1; pharmacology: Glutamates; pharmacology: Recombinant Proteins; physiology: Body Temperature; physiology: Cerebral Arteries; prevention & control: Brain Ischemia